comprehensive -WSS

comprehensive

author：focus 2025-08-19 15:02:14 - browse：1617

The back of three medicine containers, a bottle in between two boxes, all showing labels — coverage from STAT — Adobe

After a drug enters the market, it’s up to Food and Drug Administration regulators to ensure its continued safety and efficacy. A recent New York Times story suggests that, in the case of the popular asthma drug Singulair, the FDA fell short — both because the agency delayed action for years on reports from patient advocates and independent groups that the drug could cause suicidal thoughts, and because when it did add a warning label about its potential side effects in 2020, clinicians and patients still weren’t always aware of the risks.

Experts say that the Singulair incident highlights a flawed system, both in the U.S. and globally, for monitoring adverse reactions after a drug is on the market — one that will require extensive changes to address.

“The question is, how safe do you want to be?” said Ameet Sarpatwari, the assistant director of the Program on Regulation, Therapeutics, and Law at Brigham and Women’s Hospital. Ideally, he said, the FDA should be able to both stay on top of safety concerns and avoid unnecessarily restricting access to drugs. “Are we at the right balance? I think there are definitely situations for many drugs where you can say, no, we’re not really at the right balance, and the FDA should be taking a more aggressive stance in promoting patient safety.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Why the drug industry's warnings on the IRA's impact fall short

leisure time

focus

WSS

Doctors are clamoring for more clarity on Paxlovid prescribing

Democrats are overperforming in 2023's special elections. Is it a clue for Biden vs. Trump?

Sage considers ways to reduce costs following FDA rejection

Severe weather updates: 1 million customers without power in 11 states as storms pummel East Coast

Russia promises retaliation after Ukrainian drones hit a Russian tanker in 2nd sea attack in a day

Patients, doctors press FTC to beef up hospital merger scrutiny

hotspot

comprehensive

leisure time

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Bankrupt Pear's prescription app helped MassHealth save money, data suggests

Continuity nursing helped my family in our darkest PICU moments

White House Covid adviser calls on docs to combat misinformation

State Dept. review finds Biden bears some blame for Afghanistan failures

Senate bill would ban some hospital facility fees

United colonoscopy coverage change 'may cost lives,' doctors say

Akili changes sales model for its ADHD video game treatment

Medical records are filled with copy

What happened to the House vote on health price transparency?

hotspot

Russia promises retaliation after Ukrainian drones hit a Russian tanker in 2nd sea attack in a day

St. Louis police protesters begin picking up checks in $4.9 million settlement

The struggle to figure out which patients 'deserve' Wegovy

'A game

Information blocking fines are now fair game in health care

Election results set back Medicaid expansion plans

leisure time

focus

hotspot

Wikipedia